Japanese drug major Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), ...
The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...
US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...